1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29324
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWilkie M.en
dc.contributor.authorMadero M.en
dc.contributor.authorSarafidis P.A.en
dc.contributor.authorUnruh M.L.en
dc.contributor.authorWang A.Y.-M.en
dc.contributor.authorWeiner D.E.en
dc.contributor.authorCheung M.en
dc.contributor.authorJadoul M.en
dc.contributor.authorWinkelmayer W.C.en
dc.contributor.authorAdragao T.en
dc.contributor.authorAnumudu S.J.en
dc.contributor.authorChan C.T.en
dc.contributor.authorCheung A.K.en
dc.contributor.authorCostanzo M.R.en
dc.contributor.authorDasgupta I.en
dc.contributor.authorDavenport A.en
dc.contributor.authorDavies S.J.en
dc.contributor.authorDekker M.J.E.en
dc.contributor.authorDember L.M.en
dc.contributor.authorGallego D.en
dc.contributor.authorGomez R.en
dc.contributor.authorHawley C.M.en
dc.contributor.authorHecking M.en
dc.contributor.authorIseki K.en
dc.contributor.authorJha V.en
dc.contributor.authorKooman J.P.en
dc.contributor.authorKovesdy C.P.en
dc.contributor.authorLacson E.en
dc.contributor.authorLiew A.en
dc.contributor.authorLok C.E.en
dc.contributor.authorMcIntyre C.W.en
dc.contributor.authorMehrotra R.en
dc.contributor.authorMiskulin D.C.en
dc.contributor.authorMovilli E.en
dc.contributor.authorPaglialonga F.en
dc.contributor.authorPecoits-Filho R.en
dc.contributor.authorPerl J.en
dc.contributor.authorPollock C.A.en
dc.contributor.authorRiella M.C.en
dc.contributor.authorRossignol P.en
dc.contributor.authorShroff R.en
dc.contributor.authorSola L.en
dc.contributor.authorSondergaard H.en
dc.contributor.authorTang S.C.W.en
dc.contributor.authorTong A.en
dc.contributor.authorTsukamoto Y.en
dc.contributor.authorWatnick S.en
dc.contributor.authorWeir M.R.en
dc.contributor.authorWetmore J.B.en
dc.contributor.authorWilkie C.en
dc.contributor.authorLindley E.en
dc.contributor.authorPolkinghorne K.R.en
dc.contributor.authorFlythe J.E.en
dc.contributor.authorChang T.I.en
dc.contributor.authorGallagher M.P.en
dc.date.accessioned2021-05-14T09:54:28Zen
dc.date.available2021-05-14T09:54:28Zen
dc.date.copyright2020en
dc.date.created20200422en
dc.date.issued2020-04-22en
dc.identifier.citationKidney International. 97 (5) (pp 861-876), 2020. Date of Publication: May 2020.en
dc.identifier.issn0085-2538en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/29324en
dc.description.abstractBlood pressure (BP) and volume control are critical components of dialysis care and have substantial impacts on patient symptoms, quality of life, and cardiovascular complications. Yet, developing consensus best practices for BP and volume control have been challenging, given the absence of objective measures of extracellular volume status and the lack of high-quality evidence for many therapeutic interventions. In February of 2019, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference titled Blood Pressure and Volume Management in Dialysis to assess the current state of knowledge related to BP and volume management and identify opportunities to improve clinical and patient-reported outcomes among individuals receiving maintenance dialysis. Four major topics were addressed: BP measurement, BP targets, and pharmacologic management of suboptimal BP; dialysis prescriptions as they relate to BP and volume; extracellular volume assessment and management with a focus on technology-based solutions; and volume-related patient symptoms and experiences. The overarching theme resulting from presentations and discussions was that managing BP and volume in dialysis involves weighing multiple clinical factors and risk considerations as well as patient lifestyle and preferences, all within a narrow therapeutic window for avoiding acute or chronic volume-related complications. Striking this challenging balance requires individualizing the dialysis prescription by incorporating comorbid health conditions, treatment hemodynamic patterns, clinical judgment, and patient preferences into decision-making, all within local resource constraints.Copyright © 2020 International Society of Nephrologyen
dc.languageEnglishen
dc.languageenen
dc.publisherElsevier B.V.en
dc.relation.ispartofKidney Internationalen
dc.subject.meshmidodrine-
dc.subject.meshperitoneal dialysis fluid-
dc.subject.meshpropranolol-
dc.subject.meshsertraline-
dc.subject.meshspironolactone-
dc.subject.meshwearable computer-
dc.subject.meshdipeptidyl carboxypeptidase inhibitor-
dc.subject.meshblood pressure-
dc.subject.meshblood pressure measurement-
dc.subject.meshblood pressure monitoring-
dc.subject.meshblood pressure variability-
dc.subject.meshblood volume-
dc.subject.meshblood volume determination-
dc.subject.meshbody weight-
dc.subject.meshcardiovascular disease-
dc.subject.meshclinical decision making-
dc.subject.meshcontinuous ambulatory peritoneal dialysis-
dc.subject.meshdiet restriction-
dc.subject.meshdietary compliance-
dc.subject.meshdrug choice-
dc.subject.meshdrug efficacy-
dc.subject.meshdrug use-
dc.subject.meshexercise-
dc.subject.meshextracellular space-
dc.subject.meshheart arrhythmia-
dc.subject.meshheart failure-
dc.subject.meshhemodiafiltration-
dc.subject.meshhemodialysis-
dc.subject.meshhypertension-
dc.subject.meshhypervolemia-
dc.subject.meshhypotension-
dc.subject.meshkidney function-
dc.subject.meshlifestyle-
dc.subject.meshmedical-
dc.subject.meshnutritional status-
dc.subject.meshpatient preference-
dc.subject.meshperitoneal dialysis-
dc.subject.meshpractice guideline-
dc.subject.meshprescription-
dc.subject.meshquality of life-
dc.subject.meshremote sensing-
dc.subject.meshrenal replacement therapy-
dc.subject.meshsodium restriction-
dc.subject.meshultrafiltration-
dc.subject.meshamezinium metilsulfate-
dc.subject.meshamlodipine-
dc.subject.meshangiotensin receptor antagonist-
dc.subject.meshantihypertensive agent-
dc.subject.meshargipressin-
dc.subject.meshatenolol-
dc.subject.meshbeta adrenergic receptor blocking agent-
dc.subject.meshcalcium channel blocking agent-
dc.subject.meshcarnitine-
dc.subject.meshcarvedilol-
dc.subject.meshdiuretic agent-
dc.subject.meshdroxidopa-
dc.subject.meshfludrocortisone-
dc.subject.meshfosinopril-
dc.subject.meshicodextrin-
dc.subject.meshlisinopril-
dc.subject.meshmetoprolol-
dc.titleBlood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.en
dc.typeConference Paperen
dc.identifier.affiliationNephrology-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.kint.2020.01.046-
dc.publisher.placeNetherlandsen
dc.identifier.pubmedid32278617 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32278617]en
dc.identifier.source2005525254en
dc.identifier.institution(Flythe) University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, NC, United States (Flythe) Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, United States (Chang) Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, United States (Gallagher) George Institute for Global Health, Renal and Metabolic Division, Camperdown, Australia (Gallagher) Concord Repatriation General Hospital, Department of Renal Medicine, Sydney, Australia (Lindley) Department of Renal Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom (Madero) Department of Medicine, Division of Nephrology, National Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico (Sarafidis) Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece (Unruh) Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States (Wang) Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong (Weiner) William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA, United States (Cheung) KDIGO, Brussels, Belgium (Jadoul) Department of Nephrology, Cliniques universitaires Saint-Luc, Universite catholique de Louvain, Brussels, Belgium (Winkelmayer) Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, United States (Polkinghorne) Department of Nephrology, Monash Health, Clayton, Melbourne, Australia (Polkinghorne) Department of Medicine, Monash University, Clayton, Melbourne, Australia (Polkinghorne) Department of Epidemiology and Preventive Medicine, Monash University, Prahan, Melbourne, Australiaen
dc.description.addressJ.E. Flythe, University of North Carolina Kidney Center, 7024 Burnett-Womack CB #7155, Chapel Hill, NC 27599-7155, United States. E-mail: jflythe@med.unc.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.subect.keywordshemodialysis patient-reported outcome measures peritoneal dialysis quality of life residual kidney functionen
dc.identifier.authoremailFlythe J.E.; jflythe@med.unc.edu Polkinghorne K.R.; kevan.polkinghorne@monash.eduen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeConference Paper-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptNephrology-
Appears in Collections:Articles
Show simple item record

Page view(s)

92
checked on Sep 28, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.